OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced that it completed the requirements for CE IVD labeling and has significantly expanded distribution of its SURVEYOR® Scan K-RAS mutation detection kit throughout most of the European Union. The SURVEYOR Scan K-RAS CE IVD kit is a member of Transgenomic’s family of mutation detection kits, which […]
PLEASANTON, Calif. – QuantaLife, a new life science tool company developing the third generation of PCR, has received an NIH grant totaling ~$6 million over 5 years for the development of rapid, cost-effective technology for detecting methicillin-resistant Staphylococcus aureus (MRSA) infections. The grant, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of […]
CLC bio, AROS Applied Biotechnology, F. Hoffmann-La Roche, and Aarhus University Hospital – the Institute of Pathology and the Research Unit for Molecular Medicine, announced a collaboration to develop a solution for large scale use of formalin fixed, paraffin embedded (FFPE) tissue in molecular analyses. The project goal is to develop a complete platform for […]
Oxford, UK – Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today introduced the groundbreaking CytoSure™ ISCA UPD 4 x 180k array. This offers the ability, for the first time, to simultaneously detect DNA copy number variation (CNV) using OGT’s ISCA consortium endorsed 4 x 180k […]
Glasgow, Scotland – Renishaw Diagnostics Ltd, a world leading provider of trace level detection technologies based on the exploitation of Surface Enhanced Raman Spectroscopy (SERS) and Surface Enhanced Resonance Raman Scattering (SERRS) for clinical research and molecular diagnostics applications, today held its official opening of expanded premises on the Nova Technology Park. The company (previously […]
SUNNYVALE, Calif. – Cepheid (Nasdaq: CPHD) today announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.” The complete study is now available online (https://www.nejm.org) and will appear in the September 9 […]
QIAsymphony RGQ System scores with highest possible flexibility and the broadest available range of PCR-based test systems Hilden, Germany, and Germantown, MD. – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched its novel QIAsymphony RGQ system. The automated platform has been specifically designed to address the fast-growing molecular diagnostics market, particularly for applications […]
Austin, Texas – Asuragen, Inc., a leader in molecular diagnostics and nucleic acid-based pharmacogenomics services, announced today that it has launched KRAS and BRAF mutational testing services in its CAP-accredited CLIA laboratory. Asuragen’s KRAS and BRAF laboratory developed tests (LDTs) were designed in response to newly modified guidelines from the American Society of Clinical Oncology […]
HTG Announces Appointments of John Wineman as Vice President New Business Development–Western Region and Thomas Vasicek, Ph.D. as Vice President Clinical Programs and Product Innovation TUCSON, Ariz. – HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced the appointments of John Wineman as Vice President New Business Development, Western Region and Thomas […]
Enzo Biochem’s Clinical Lab Takes Major Step in Becoming National Provider of Predictive Diagnostics
Pennsylvania Grants Lab License to Operate, With Several Others Pending NEW YORK – In the first of several moves to expand the Company’s position as a national provider of esoteric and high value diagnostics, Enzo Biochem, Inc. /quotes/comstock/13*!enz/quotes/nls/enz (ENZ 3.67, +0.12, +3.38%) announced today that its Enzo Clinical Labs division has been awarded a license […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
